Disease |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
kidney cancer |
N/A |
N/A |
N/A |
expression |
Diagnostic and discriminative marker |
24373479 |
LncRNADisease
|
Cardiovascular disease |
N/A |
N/A |
N/A |
N/A |
Clopidogrel reduces apoptosis and promotes proliferation of human vascular endothelial cells induced by palmitic acid via suppression of the long non-coding RNA HIF1A-AS1 in vitro. |
25761653 |
LncRNADisease
|
kidney cancer |
qPCR etc. |
renal cancer tissue |
up-regulated |
expression |
The antitumor DNA topoisomerase I (Top1) inhibitor camptothecin (CPT) increases the cellular levels of two antisense lncRNAs at the 5' (5'aHIF-1 alpha) and 3' (3'aHIF-1 alpha) ends of the human HIF1A-AS1 gene. |
21897117 |
LncRNADisease Lnc2Cancer
|
non-small cell lung cancer |
qPCR etc. |
blood (serum), NSCLC tissue |
up-regulated |
expression |
The levels of XIST (P < 0.05) and HIF1A-AS1 (P < 0.05) were significantly increased in tumor tissues or serum from NSCLC patients as compared to those of control group. Moreover, serum levels of XIST and HIF1A-AS1 were significantly decreased after surgical treatment as compared to pre-operative. |
26339353 |
Lnc2Cancer
|
aneurysm of the thoracoabdominal aorta |
RT-PCR |
VSMCs, serum of TAA patients |
up-regulated |
expression |
HIF1a-AS1 was overexpressed in the thoracoabdominal aorta aneurysm and the interaction between HIF1a-AS1 and apoptotic proteins plays a key role in the proliferation and apoptosis of VSMCs in vitro, which may contribute to the pathogenesis of thoracoabdominal aorta aneurysm. |
25550800 |
|
|